Corporate Corruption News Stories
Below are key excerpts of revealing news articles on corporate corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.
Former City trader Tom Hayes has been found guilty at a London court of rigging global Libor interest rates. He was sentenced to 14 years in prison for conspiracy to defraud. The 35-year old is the first individual to face a jury trial for manipulating the rate, which is used as a benchmark for trillions of pounds of global borrowing and lending. Many of the world's leading banks have paid heavy financial penalties for tampering with the key benchmark. The case was brought by the Serious Fraud Office, which said Hayes set up a network of brokers and traders spanning 10 financial institutions and cajoled or bribed them to help rig Libor rates for profit. During the trial, jurors were told that Hayes promised to pay a broker up to $100,000 to keep the Libor rate "as low as possible". Defence barrister Neil Hawes asked the judge to take into account the prevalence of Libor manipulation at the time, and also that ... managers and senior managers at Hayes' bank knew of, and in some cases condoned, Libor manipulation. Hayes ... rigged the Libor rates daily for nearly four years while working in Tokyo for UBS, then Citigroup, from 2006 until 2010. Rigging even minor movements in the rate can result in bumper profits for a trader manipulating the rates, or the rate can be moved simply to make a bank look more creditworthy.
Note: Why aren't we hearing about the many other high-level bankers who rigged the Libor rate? For more along these lines, see concise summaries of deeply revealing news articles about the systemically corrupt financial industry.
A court has heard that manipulating Libor rates was so commonplace an offer of a Mars bar could get it changed. Tom Hayes, who worked for UBS and Citigroup ... is the first person to face a jury trial for manipulating the key interest rate, used to set trillions of pounds of investments. The court was shown ... transcripts of exchanges between traders using UBS's internal messaging system. The conversations all related to moving Libor rates, said Mr Hayes, to assist the traders' and banks' commercial interests, something he said he found it hard to see as wrong. In one chat, Mr Hayes suggests the market is rife with dealers attempting to influence rates: "Very, very hard to price stuff with the fixes so manipulated and inconsistent." His correspondent replies: "The fixes are manipulated?" "Yes, of course they are," says Mr Hayes. "Just give the cash desk a Mars bar and they'll set wherever you want." He has alleged throughout his trial that ... senior managers, even the chief executive of the bank, knew all about it. He said he was "shocked" when his manager phoned him asking him not to mention Libor rate-setting in any emails. The court was also shown an email exchange between senior management appearing to show they had reservations about Mr Hayes. "Personally I find it embarrassing when he calls up his mates to ask for favours on high/low fixings. What's the legal risk to UBS asking others to manipulate rates?" The Libor scandal has seen a number of the world's leading banks fined for manipulating rates.
Note: For more along these lines, see concise summaries of deeply revealing news articles about the systemically corrupt financial industry.
The United Nations has spent half a billion dollars on contracts with a Russian aviation company since discovering one of its helicopter crews in the Democratic Republic of the Congo drugged and raped a teenage girl in a sexual attack. The girl was dumped naked and unconscious inside the helicopter base. Internal UN documents, marked strictly confidential and leaked to the Guardian, reveal how the UNs internal complaints unit uncovered evidence the woman was abused ... by the manager in charge of UTairs base in Kalemie, eastern DRC. The main investigative report, from March 2011, warned of a possible culture of sexual exploitation and abuse at UTair. Copies of that report were circulated among top officials at the UN. The company was permitted to continue doing business with the UN on the condition it introduce a new training regime overseen by a monitor. The disclosures come at a critical moment for the UN secretary general, who has struggled to contain the fallout from recent revelations concerning the sexual abuse of children by French and other peacekeeping troops in the neighbouring Central African Republic. It wasnt just one or two bad apples, said a senior UN official familiar with the report and its fallout. It was clear the problems of sexual exploitation were wider. In total, the company ... has been granted contracts worth $543.3m for services provided in 11 countries since the UN became aware it had a problem with sexual exploitation.
Note: Watch powerful evidence in a suppressed Discovery Channel documentary showing that child sexual abuse scandals reach to the highest levels of government. For more along these lines, see concise summaries of deeply revealing news articles on sex abuse scandals from reliable major media sources.
There are constitutional requirements for providing adequate health care to our incarcerated populations. In 1976, the U.S. Supreme Court decided in Estelle v. Gamble that deliberate indifference to serious medical needs of prisoners constitutes the unnecessary and wanton infliction of pain ... proscribed by the Eighth Amendment. In 1993, in Helling v. McKinney, the court decided that prison officials cannot expose inmates to environments that pose an unreasonable risk of serious damage to their future health. Since then, however, frequent reports and lawsuits ... strongly suggest that many U.S. prisons and jails have ignored these rulings. Allegations of subpar care in Arizona provide a good example of how correctional health care dysfunction puts cancer patients at extreme risk. In March 2012, the ACLU and allied prisoners rights groups filed a lawsuit against the Arizona Department of Corrections (ADC) and several state officials [that] points to several cases of what it describes as poorly treated, or untreated, cancer. The American Friends Service Committee-Arizona released a report in October 2013 [which] found that some 105 prisoners died in custody from March 2012 to June 2013. The AFSC studied 14 deaths in depth. Six involved metastatic cancers. This clearly indicates that the conditions were long-standing and suggests that these deaths might have been preventable had the individuals received more timely care, the report charges.
Note: In 2013, the ADC terminated its contract with prison health contractor Wexford. A billion dollar company named Corizon then got the lucrative contract. According to the New York Times, inmate deaths increase at Corizon-serviced facilities. For more along these lines, see concise summaries of deeply revealing news articles about the corrupt prison industry.
As complaints grow about exorbitant drug prices, pharmaceutical companies are coming under pressure to disclose the development costs and profits of those medicines and the rationale for charging what they do. So-called pharmaceutical cost transparency bills have been introduced in at least six state legislatures in the last year, aiming to make drug companies justify their prices, which are often attributed to high research and development costs. If a prescription drug demands an outrageous price tag, the public, insurers and federal, state and local governments should have access to the information that supposedly justifies the cost, says the preamble of a bill introduced in the New York State Senate in May. In an article being published Thursday, more than 100 prominent oncologists called for support of a grass-roots movement to stem the rapid increases of prices of cancer drugs, including by letting Medicare negotiate prices with pharmaceutical companies and letting patients import less expensive medicines from Canada. There is no relief in sight because drug companies keep challenging the market with even higher prices, the doctors wrote in the journal Mayo Clinic Proceedings. Pressure is mounting from elsewhere as well. The top Republican and Democrat on the United States Senate Finance Committee last year demanded detailed cost data from Gilead Sciences, whose hepatitis C drugs, which cost $1,000 a pill or more, have strained the budgets of state and federal health programs.
Note: For more along these lines, see concise summaries of deeply revealing news articles about big pharma profiteering from reliable major media sources.
Beginning in 1997, Pharmacia, currently a subsidiary of Pfizer, sought to boost its sales of the drug Genotropin. To that end, the company illegally marketed the drug to spur growth in short children and as an anti-aging drug for adults looking for the fountain of youth. In a nutshell, the off-label marketing scheme included direct payments to doctors, all-expense paid junkets for doctors, financial incentives to distributors and phony consultant contracts to funnel payments for the off-label promotion. As a result of the scheme's success, sales of the Genotropin sky-rocketed and over the years, Medicaid and other public healthcare programs paid millions of dollars for its improper use. The full amount of damage to health care programs is not yet known. "But this much is certain," former Pfizer Vice President turned whistleblower, Dr Peter Rost, says, "Pharmacia turned Genotropin into a cash cow by illegally peddling a dangerous drug to make short kids tall and their grandparents young." Genotropin is a man made human growth hormone approved to treat a limited range of hormonal deficiencies. The FDA has never approved the drug to spur growth for children without hormonal deficiencies or to prevent aging. Dr Rost joined Pharmacia in June of 2001 as a VP of Marketing. On May 22, 2003, Dr Rost became aware of the pervasive nature of ongoing illegal activity. [He then] decided to file a lawsuit ... alleging fraud relating to the off-label marketing of Genotropin and delivered a copy of the complaint to the US Attorney's Office on June 4, 2003.
Note: Read an excellent article on Dr. Rost and other major whistleblowers from the pharmaceutical industry.
Eric Holder has gone back to work for his old firm, the white-collar defense heavyweight Covington & Burling. Holder will reassume his lucrative partnership (he made $2.5 million the last year he worked there) and take his seat in an office that reportedly was kept empty for him in his absence. At issue is the extraordinary run Holder just completed as one of history's great double agents. For six years, while brilliantly disguised as the attorney general of the United States, he was actually working deep undercover ... as the best defense lawyer Wall Street ever had. After six years of letting one banker after another skate on monstrous cases of fraud, tax evasion, market manipulation, money laundering, bribery and other offenses [by] handing out soft-touch settlements to practically every Too Big to Fail bank in the world, [Holder] returns to a firm that represents many of those same companies: Morgan Stanley, Wells Fargo, Chase, Bank of America and Citigroup, to name a few. Going by the massive rises in share price observed after he handed out these deals, his service was certainly worth many billions of dollars to Wall Street. Now he will presumably collect assloads of money from those very same bankers. It's one of the biggest quid pro quo deals in the history of government service. Holder ... institutionalized a radical dualistic approach to criminal justice, essentially creating a system of indulgences wherein the world's richest companies paid cash for their sins and escaped the sterner punishments the law dictated.
Note: The revolving door between Wall Street and government officials is well known. But in Holder's case, the corporate door remained wide open throughout his time as a public servant. For more along these lines, see concise summaries of deeply revealing news articles about corruption in government and in the corporate world.
JPMorgan Chase has agreed to pay at least $125 million to settle probes by U.S. state and federal authorities that the bank sought to improperly collect and sell consumer credit card debt. The settlement also includes about $50 million in restitution. The nation's largest bank has been accused of ... going after consumers for debts they may not have owed and for providing inaccurate information to debt buyers. The U.S. Consumer Financial Protection Bureau (CFPB), 47 states and the District of Columbia are expected to announce the settlements as soon as Wednesday. Mississippi and California are not expected to settle at the same time. Both have lawsuits pending against JPMorgan over debt collection practices. California Attorney General Kamala Harris sued in 2013, claiming the bank engaged in fraudulent and unlawful debt collection practices against 100,000 California credit card borrowers over some three years. The state claims the bank flooded state courts with questionable lawsuits, filing thousands every month, including 469 such lawsuits in one day alone. Mississippi Attorney General Jim Hood's lawsuit filed a similar lawsuit against JPMorgan in 2013. In September 2013, the U.S. Consumer Financial Protection Bureau ordered JPMorgan to refund $309 million to about 2 million customers for illegal credit card practices, including charging consumers for credit card monitoring services they did not receive.
Note: Read how JPMorgan Chase uses settlements like the ones described above to hide criminal wrongdoing while actually making money in "The $9 Billion Witness". For more along these lines, see concise summaries of deeply revealing news articles about the systemically corrupt financial industry.
A report by the Environmental Protection Agency (EPA) last month found that hydraulic fracturing for oil and gas can lead, and has led, to the contamination of drinking water. It was the first time the federal government had admitted such a link. But Gretchen Goldman, a lead analyst at the Center for Science and Democracy at the Union for Concerned Scientists, told the Guardian that the EPAs study which is now open for comment was nothing more than a literature review and called for the industry to be required to divulge greater data. Goldman says the EPA backed down from its initial promise to undertake prospective studies, which would have involved following a well site and testing its waters before, during and after fracking activities had begun. Such a study would have shed objective light on the fracking process and pushed scientific knowledge forward, she says. Even when companies were forced to share information through state regulations, they were still allowed to withhold ... the identity and mixture of chemicals that are injected into the ground through wells, together with water, at high intensity to fracture underground rocks and release oil or gas. In 2005 lobbying efforts by the oil and gas industry proved successful, with hydraulic fracturing activities exempted from certain sections of the Safe Drinking Water Act, including permit application.
Note: For more along these lines, read this Los Angeles Times article about how fracking poisons drinking water, and see concise summaries of deeply revealing corporate corruption news articles from reliable major media sources.
Hydraulic fracturing uses a host of highly toxic chemicals that could be contaminating drinking water supplies, wildlife and crops, according to a report released Thursday by a California science panel. The long-awaited final assessment from the California Council on Science and Technology said that because of data gaps and inadequate state testing, overwhelmed regulatory agencies do not have a complete picture of what oil companies are doing. The risks and hazards associated with about two-thirds of the additives used in fracking are not clear, and the toxicity of more than half, the report concluded, remains uninvestigated, unmeasured and unknown. Basic information about how these chemicals would move through the environment does not exist. Seth Shonkoff, lead author on the public health sections of the report, said he was surprised to learn during his research that recycled wastewater from oil fields was being used on crops. We've got to know what to test for ... to know that what we are putting onto the crops is safe, he said. Until we have that data, I don't know how we can assure farmers and consumers that their food is safe. Among the findings of the report: Oil operations in federal waters offshore are discharging wastewater directly into the ocean, against EPA regulations, more than half the produced water from fracked wells is disposed of in unlined pits, [and] about one-third of the oil field wastewater pits in the Central Valley are operating without proper permits.
Note: For more along these lines, read this Los Angeles Times article about how fracking poisons drinking water, and see concise summaries of deeply revealing corporate corruption news articles from reliable major media sources.
Peter Rost is worked up. The ex-Pfizer senior executive turned blogger believes he has uncovered another instance of unethical marketing by Big Pharma. Rost's blog, Question Authority With Dr. Rost, is one part mocking rant, two parts investigative chronicle. He has also published an expos of his years in the drug industry, "The Whistleblower: Confessions of a Healthcare Hitman." Trained as a physician in his native Sweden, Rost has worked in the drug industry for most of the past 20 years. He almost certainly never will again. Rost hopes that Question Authority - named after the Fortune column in which he was once featured - will help him create a new career. Rost's many critics would love to be able to dismiss him as an embittered crank. But they can't. The blog [is] a conduit for Big Pharma whistleblowers [that once prompted] a government probe into Pfizer's marketing activities. And a dispatch on dubious sales practices led to at least one sales director's ouster. For Big Pharma, whose public image is already battered, blogs are an added nuisance. The problem, says Robert Ehrlich, CEO of DTC Perspectives, a health-care marketing consultancy, is that most pharma companies are, "medically oriented and legally oriented ... but as an industry they are not consumer-oriented." For better or worse, the drug industry is going to have to get used to Dr. Peter Rost - and others like him.
Note: Read an excellent article on Dr. Rost and other major whistleblowers from the pharmaceutical industry. For more along these lines, see concise summaries of deeply revealing big pharma corruption news articles from reliable major media sources.
What if your life depended on a drug that cost half a million dollars a year, every year, for the foreseeable future? That's the price of Soliris, one of the world's most expensive drugs. It is the only medicine available for people suffering from two ultra-rare diseases. And for both diseases, Soliris is not a cure, but ... patients can go back to living normal lives. But only if they can get the drug, and many can't, because it is priced beyond the reach of almost everyone. So how can one drug cost more than the annual income of all but a tiny percentage of households? The reason is ... orphan drug pricing, where actual research and development costs are carefully guarded secrets known only to drug company executives. "Orphan" in this context refers to rare diseases [for which] the patient population was too small to attract the interest of drug companies. But now medications to treat these ultra-rare diseases are becoming more profitable than traditional drugs, because of ... a business model based on extreme pricing. The extreme prices of these new orphan drugs are largely arbitrary, and have very little to do with the development and manufacturing costs. Most drugs are based on scientific discoveries made in publicly funded research labs, by academic scientists. In case of Soliris, most of the research and development was done by university researchers working in academic laboratories supported by public funds. Soliris is Alexion's only drug, but it's a blockbuster, earning revenues of more than $6 billion in just eight years, and making Alexion one of the fastest growing companies in the world.
Note: For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical corruption from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.
The prison phone business is a wildly complex, fiercely secretive and enormously lucrative industry. Over the last decade, [this] business has become a scandalous industry, characterized by lawsuits, exorbitant fees, high phone rates and monopolistic relationships between public jails and private companies that openly offer kickbacks to local sheriffs. "This is about shifting the cost of the police state onto the backs of the poor people being policed," says Paul Wright, executive director of Human Rights Defense Center. [There are] an estimated 2.2 million inmates currently behind bars in America. If you've ever tried to call an inmate, there's a good chance you've heard of Securus, or its main competitor, Global Tel*Link (GTL). The two companies reportedly make up about 80 percent of the prison phone business, which drives about $1.2 billion per year in revenues. In the last few years, Securus, especially, has emerged into one of the largest, if not most secretive, prison technology companies in the business. The company employs 1,000 associates in 46 states, contracts with 2,600 jails and prisons across North America, and provides service to more than 1 million inmates and their families. Securus earned $114.6 million in profits 2014, on revenues of about $404 million. When companies like Securus send proposals to jails and prisons around the country, they offer a percentage of the call rate back to the sheriff's office. It's typical for commissions to range anywhere from 40 percent and 80 percent.
Note: Read more in this Huffington Post article. For more along these lines, see concise summaries of deeply revealing news articles on prisons corruption from reliable major media sources.
After an arm of the U.N.'s World Health Organization (WHO) identified the main ingredient in Monsanto's popular weed killer Roundup as "probably carcinogenic to humans," France has taken a step to limit sales of the herbicide. On Sunday, French Ecology Minister Segolene Royal announced that the government would ban the sale of Roundup at garden centers in the country. Roundup and generic versions of glyphosate are still the most widely used herbicides in the world, among farmers and municipalities alike. As of 2012, it was the top choice of New York City for killing weeds in its parks. Farmers like Roundup because "Roundup Ready" versions of crops like corn and soybeans have been modified to specifically tolerate the herbicide, allowing growers to spray Roundup widely across their fields without damaging their crops. Shortly after the WHO announcement, Patrick Moore, who has an ecology Ph.D. and is a controversial defender of genetically modified crops, offered to drink Roundup on French television to prove its safety. But when a TV host offered him a glass of the stuff, Moore refused, and the video of the exchange quickly went viral online.
Note: The Netherlands, Bermuda, and Sri Lanka preceded France in banning over the counter sales of Roundup. Watch a revealing documentary showing how Monsanto ruthlessly pursued farmers to stop them from planting their own seeds and corrupted judges to illegally support their efforts. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.
If companies don't ... focus on "internal equity" – how the highest paid executive's pay compares with that of everyone else in the organization – they risk losing their own staff's dedication and focus. Indeed, a bias to focus only on the external market in recent years has helped push executive compensation way out of whack. Because of the yawning gap between the leaders and the led, employee morale is suffering, talented performers' loyalty is evaporating, and strategy and execution is suffering at American companies. A smaller gap makes for greater solidarity, and as a result better performance, throughout the workplace. At Whole Foods, we've made adjustments to keep the external and internal equity perspectives in balance. We have a salary cap – the maximum allowable ratio of the highest cash compensation to average employee cash compensation. Today it's 19 to 1. The maximum cash compensation anyone can make at Whole Foods at about $650,000. Whole Foods has never lost to a competitor a top executive that we wanted to keep since the company began more than 30 years ago. The truth is that maximizing personal compensation is not the only motivation that people have in their work. We discover that once our basic material needs are satisfied, money becomes less important to us. In my experience, deeper purpose, personal growth, self-actualization, and caring relationships provide very powerful motivations and are more important than financial compensation for creating both loyalty and a high performing organization.
Note: This article was written by the CEO of Whole Foods, John Mackey. For more along these lines, see concise summaries of deeply revealing news articles on income inequality from reliable major media sources.
Lego just announced a bold 10-year plan to makes its goods more environmentally friendly. This comes after a 2013 partnership with the World Wildlife Fund to develop a plan in reducing its overall carbon emissions, as well as those of its supply chain. Lego pledged to invest $150 million to find a replacement for the plastic used in its blocks as well as to reduce the size of its packaging. A commitment for this kind of strategy includes using recycled or renewed materials and improving the recyclability of its products. Hasbro and Mattel, producers of such iconic toys as Play-Doh and Hot Wheels, respectively, have also vowed to invest in this global issue. By 2020, Hasbro plans to reduce its waste, water, energy, and greenhouse gas emissions. It is also overhauling the packaging for most of its brands. These strides have led to Hasbro being named a winner of the EPA's 2014 Climate Leadership Award. After caving to mounting pressure from Greenpeace, Mattel committed to source new materials for its packaging, setting a goal of 85 percent recycled materials by the end of 2015. "The investment announced is a testament to our continued ambition to leave a positive impact on the planet, which future generations will inherit," said Lego Group owner Kjeld Kirk Kristiansen. Words we should all try to live by.
Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.
Neil Young ... has a new album coming out at the end of June called "The Monsanto Years." And it's a biting attack on the seed giant -- as well as other big corporations. The title track refers to "the poison tide of Monsanto" and describes a farmer who "signs a deal for GMOs that makes life hell with Monsanto." Young also lashes out at Starbucks in a song called "A Rock Star Bucks a Coffee Shop." "I want a cup of coffee but I don't want a GMO. I like to start my day off without helping Monsanto," Young sings in his trademark nasal whine. The singer announced ... that he would no longer drink Starbucks lattes because the company, along with Monsanto, was part of the Grocery Manufacturers Association trade group. That organization sued the state of Vermont to overturn a law that would require food and beverage companies to disclose on their labels if GMOs are used in the products. "GMO labeling matters. Mothers need to know what they are feeding their children. They need freedom to make educated choices at the market," Young said. Young also rails against the Supreme Court's Citizens United ruling on campaign finance in several songs. And he criticizes Walmart's labor practices in a song called "Big Box," which has the following verse: "People working part-time at Walmart never get the benefits for sure." So far, it looks like Walmart isn't planning to retaliate against Young. You can preorder "The Monsanto Years" at Walmart.com.
Note: For more along these lines, see concise summaries of deeply revealing genetic modification news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.
More than 300 international companies including Pepsi, Ikea, FedEx, AIG, Deutsche Bank and Abbott Laboratories allegedly secured secret deals from Luxembourg to drastically reduce their global tax bills. The International Consortium of Investigative Journalists (ICIJ), citing leaked documents, reported that the companies appear to have channelled hundreds of billions of dollars through the European duchy, and saved billions of dollars in taxes. PricewaterhouseCoopers is alleged to have helped multinational companies obtain at least 548 tax rulings in Luxembourg from 2002 to 2010. These legal secret deals allegedly feature complex financial structures designed to create drastic tax reductions. The rulings provide written assurance that companies' tax-saving plans will be viewed favourably by Luxembourg authorities. Some firms have allegedly enjoyed effective tax rates of less than 1% on the profits they've shuffled into Luxembourg. The ICIJ claims to have reviewed 28,000 pages of confidential documents before reaching its conclusion. The documents include hundreds of private tax rulings, known as "comfort letters", that Luxembourg provides to corporations seeking favourable tax treatment. Earlier, the European Union (EU) initiated a probe on Luxembourg over its tax treatment of big companies such as Amazon and Fiat Finance, which apparently violated European law. Luxembourg officials have supplied some information to the EU in connection with the investigation but have refused to provide a larger set of documents relating to its tax rulings.
Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption from reliable major media sources.
Retailers have the ability to scan your face digitally, and use that identification to offer you special prices or even recognize you as a prior shoplifter. But should they use it? Should they get your permission first? Privacy advocates announced Tuesday they have walked away from a government-run effort with industry intended to ... hash out voluntary protocols for facial recognition technology in a way that doesn't hurt consumers. The Commerce Department's National Telecommunications and Information Administration, or NTIA, was acting as mediator. The two sides had been meeting for 16 months ... until the nine major privacy groups said they had hit a dead end and that "people deserve more protection than they are likely to get in this forum. At a base minimum, people should be able to walk down a public street without fear that companies they've never heard of are tracking their every movement and identifying them by name using facial recognition technology," the groups said. "We have been unable to obtain agreement even with that basic, specific premise." The ability to apply a unique signature to a person's face, even if you don't identify them by name, is particularly invasive, according to privacy advocates. "You can change your password and your credit card number; you cannot change your fingerprints or the precise dimensions of your face. Through facial recognition, these immutable, physical facts can be used to identify you, remotely and in secret, without any recourse."
Note: Read this article for more in this matter. Remember, the same technologies that lead to the disappearance of privacy rights for individuals are also used by corrupt corporations against nonprofit civic organizations to undermine democracy.
The leak of new information on the Trans-Pacific Partnership agreement (TPP) shows the mega-trade deal could provide more ways for multinational corporations to influence Australias control of its pharmaceutical regulations. Revealed via Wikileaks, the annexe on transparency and procedural fairness for pharmaceutical products and medical devices uncovered the draft agreements regarding medicines between the 12 TPPA member countries [representing] 40% of the worlds economy. The leaked text, dated December 2014, laid out the draft rules for member countries regarding medicines under national health care programs, in Australias case, the Pharmaceutical Benefits Scheme (PBS). This transparency annexe seeks to erode the processes and decisions of agencies that decide which medicines and medical devices to subsidise the public money and by how much. That will mean fewer medicines are subsidised, or people will pay more as co-payments. However, [trade minister Andrew] Robb said ... that the government would not accept anything that would adversely affect the PBS. Parliamentarians were offered the chance to see the TPP draft by Robb [only] if they agreed to a four year non-disclosure agreement. Senator Peter Whish-Wilson ... who has not seen the draft as he refused to agree to the terms of the agreement, said the latest leak suggested the Australian PBS could be undermined.
Note: The Trans-Pacific Partnership may be a pending disaster. But we do not know for sure, because its contents remain secret. For more along these lines, see concise summaries of deeply revealing news articles about corruption in government and in the corporate world.
Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
